NYSE$IQV

IQVIA Holdings Inc. · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

IQVIA had a record quarter driven by strong double-digit growth and free cash flow conversion.

IQVIA reported strong first-quarter results with revenue of $3,409 million, a 23.8% increase year-over-year, and adjusted diluted earnings per share of $2.18, a 45.3% increase year-over-year. The company raised its full-year 2021 guidance for revenue, Adjusted EBITDA and Adjusted Diluted EPS.

  • Revenue of $3,409 million for the first quarter grew 23.8 percent year-over-year
  • Adjusted EBITDA of $744 million for the first quarter increased 32.4 percent year-over-year
  • GAAP Diluted Earnings per Share of $1.09 for the first quarter; Adjusted Diluted Earnings per Share of $2.18 for the first quarter grew 45.3 percent year-over-year
  • R&D Solutions contracted backlog of $23.2 billion grew 18.3 percent year-over-year; next twelve months revenue from backlog increased to $6.5 billion, up 31.1 percent year-over-year

Headline financials

Total Revenue

$3.41B

Previous: $2.75B+23.8%
EPS (adj)

$2.18

Previous: $1.50+45.3%
R&D Solutions contracted backlog

$23.2B

Previous: $19.6B+18.4%
Free Cash Flow

$212M

Previous: $82M+158.5%
Net Income

$212M

Previous: $82M+158.5%
Operating Income

$342M

Previous: $193M+77.2%
Gross Profit

$731M

Previous: -$1.82B+140.1%
Cash & Equivalents

$2.31B

Previous: $927M+148.7%
Total Assets

$24.5B

Previous: $23.1B+6.0%
Stock-Based Comp

$32M

No prior period

Revenue & EPS history

IQVIA · Revenue · Quarterly

$3.41B

Q1 2021+23.8%vs Q1 2020
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

IQVIA · $3.41B total across 3 segments · Q1 2021

  • Research & Development Solutions
    $1.87B+29.6%
  • Technology & Analytics Solutions
    $1.35B+20.7%
  • Contract Sales & Medical Solutions
    $193M-1.5%

Forward guidance

For the second quarter of 2021, the company is providing guidance as follows: Revenue $3,225 - $3,300 million, Adjusted EBITDA $690 - $715 million, Adjusted Diluted EPS $2.00 - $2.10.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+1.4%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+1.9%

Avg return

30 days after

65%

37 / 57 earnings

Positive

+12.5%

Q2 2018

Best reaction

-10.7%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+7.7%+10.9%+13.9%
Q4 2025-10.7%-9.9%-13.8%
Q3 2025+0.3%-0.4%+6.6%
Q2 2025-0.4%+1.1%-1.6%
Q1 2025-4.0%-2.2%-3.2%
Q4 2024+2.2%-2.2%-6.7%
Q3 2024-3.2%-1.5%-7.0%
Q2 2024+6.3%+6.7%+10.0%
Q1 2024-4.1%-1.6%-5.9%
Q4 2023+12.2%+10.8%+17.4%
Q3 2023+5.3%+9.7%+20.0%
Q2 2023-2.1%-3.1%-0.5%
Q1 2023-0.9%-2.3%+5.0%
Q4 2022+0.8%-1.4%-14.4%
Q3 2022+1.4%+6.1%+11.3%
Q2 2022+0.5%-0.4%+8.3%
Q1 2022+6.1%+5.0%+6.7%
Q4 2021-3.2%-4.8%-6.9%
Q3 2021+2.1%+1.8%+6.6%
Q2 2021-0.8%+0.2%+4.5%
Q1 2021+6.1%+7.0%+9.1%
Q4 2020+4.9%+4.8%+1.6%
Q3 2020+3.2%+2.1%+3.4%
Q2 2020+2.9%+3.4%+0.4%
Q1 2020+8.5%+3.5%+10.9%
Q4 2019+2.5%+1.6%-26.6%
Q3 2019-3.8%-2.4%-2.7%
Q2 2019+2.1%+1.6%-2.3%
Q1 2019-2.0%-0.1%-2.2%
Q4 2018+7.6%+7.3%+7.4%
Q3 2018-3.5%-5.3%-8.4%
Q2 2018+12.5%+8.2%+11.7%
Q1 2018-0.7%+0.2%+2.6%
Q4 2017+1.5%+1.7%+5.6%
Q3 2017+6.1%+6.5%+2.7%
Q2 2017-1.3%-1.0%+4.4%
Q1 2017-3.7%-2.0%+3.0%
Q4 2016-2.7%-4.1%+0.5%
Q3 2016+0.8%+4.1%+3.3%
Q2 2016+3.3%+4.2%+0.3%
Q1 2016-5.9%
Q4 2015+3.6%
Q3 2015-6.2%
Q2 2015+2.6%
Q1 2015-4.9%
Q4 2014+4.3%
Q3 2014+0.9%
Q2 2014-3.1%
Q1 2014+0.4%
Q4 2011+7.5%
Q4 2013+7.5%
Q3 2012+0.1%
Q3 2013+0.1%
Q2 2012+0.8%
Q2 2013+0.8%
Q1 2012+5.0%
Q4 2012+5.0%
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro